We have also previously studied the methylation levels of KCNJ11 and ABCC8 in another cohort of T2DM patients regarding their response to antidiabetic therapy, and we were interested in investigating further their use as biomarker of T2DM [30]. The gene discussed is KCNJ11; the disease is type 2 diabetes mellitus.